GCTK · Glucotrack, Inc.
$0.37
+0.00 (+0.52%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based upon this review and our current financial condition, we have concluded that substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.89M
Shares
10.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.37
Open$0.37
Day$0.37–0.39
52W close$0.29–10.59
Avg vol 30d22.0M
Short int2.6M · 24.2% float · 1.0d
Short vol43%
DataJun 2025–Aug 2026
Filing10-Q · Aug 14
Raw chart and full-history price indicators begin at the captured split on Jun 16, 2025; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−11%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−25%
trailing
6-month return
−76%
trailing
YTD return
−91%
this year
Relative strength
−89%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+46% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
24.15% of float · ▲ +7.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
19 holders — near 3-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
+2883886%
Y/Y
EPS growth
−99%
Y/Y
Free cash flow
$-15.3M
Balance sheet
$7.1M
net cash
Quant / Vol
risk profile
Volatility
253%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
28.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−11%
Bearish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+46% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
24.15% of float · ▲ +7.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
19 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $0
Now $0 · 1%
Range high $11
vs 200-day avg -83%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GCTK
this stock
Glucotrack, Inc.
|
$3.89M | -90.5% | +2883885.7% | — | 24.2% |
|
ABT
Abbott Laboratories
|
$193.78B | -11.2% | +5.7% | 31.2 | 1.3% |
|
SYK
Stryker Corp
|
$130.11B | -3.5% | +11.2% | 35.2 | 2.2% |
|
MDT
Medtronic plc
|
$116.83B | -5.0% | +8.4% | 24.5 | 1.4% |
|
BSX
Boston Scientific Corp
|
$75.11B | -45.6% | +12.5% | 21.0 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
Raw-price comparisons begin at the captured split on Jun 16, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GCTK | -15.0% | -25.3% | -75.7% | -23.0% | -90.5% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -15.4% | -29.8% | -89.4% | -26.9% | -104.4% |